HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amparo Estepa Selected Research

Viral Hemorrhagic Septicemia

1/2017Identification of diverse defense mechanisms in rainbow trout red blood cells in response to halted replication of VHS virus.
2/2015Transcriptome analysis of rainbow trout in response to non-virion (NV) protein of viral haemorrhagic septicaemia virus (VHSV).
1/2014Transcriptome profiles associated to VHSV infection or DNA vaccination in turbot (Scophthalmus maximus).
7/2013pH-dependent solution structure and activity of a reduced form of the host-defense peptide myticin C (Myt C) from the mussel Mytilus galloprovincialis.
6/2011Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae.
6/2005The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV).
8/2004Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amparo Estepa Research Topics

Disease

21Infections
04/2017 - 06/2005
7Viral Hemorrhagic Septicemia
01/2017 - 08/2004
5Virus Diseases (Viral Diseases)
01/2017 - 01/2013
4Hemorrhagic Septicemia (Haemorrhagic Septicemia)
11/2015 - 09/2010
3Viremia
11/2015 - 01/2013
2Superinfection
04/2017 - 11/2016
2Necrosis
02/2015 - 01/2013
1Premature Aging
10/2019
1Inflammation (Inflammations)
01/2017
1Hemorrhage
11/2015
1Vesicular Stomatitis
09/2014
1Carcinoma (Carcinomatosis)
10/2013
1Persistent Infection
10/2013

Drug/Important Bio-Agent (IBA)

11Antiviral Agents (Antivirals)IBA
04/2017 - 06/2005
5Glycoproteins (Glycoprotein)IBA
09/2014 - 06/2011
4RNA (Ribonucleic Acid)IBA
04/2017 - 08/2004
3Proteins (Proteins, Gene)FDA Link
01/2017 - 09/2010
3VaccinesIBA
01/2016 - 09/2010
2Protein Isoforms (Isoforms)IBA
01/2017 - 07/2013
2erucylphosphocholineIBA
11/2016 - 10/2013
2Poly I-CIBA
01/2016 - 09/2008
2Transcription Factors (Transcription Factor)IBA
02/2015 - 01/2013
2DNA VaccinesIBA
01/2014 - 01/2013
2guanylyl-(3'-5')-guanosineIBA
01/2013 - 06/2011
1AntioxidantsIBA
10/2019
1Acetylcarnitine (Alcar)IBA
10/2019
1navitoclaxIBA
10/2019
1InterferonsIBA
01/2017
1Caspase 3 (Caspase-3)IBA
01/2017
1FicollIBA
01/2017
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2017
1CytokinesIBA
01/2016
1tiplaxtininIBA
11/2015
1Tannic AcidFDA Link
11/2015
1Peptides (Polypeptides)IBA
11/2015
1SerpinsIBA
11/2015
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
11/2015
1InterleukinsIBA
02/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2015
1Activating Transcription Factor 1IBA
02/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015
1Epidermal Growth Factor (EGF)IBA
01/2015
1Mitogen-Activated Protein KinasesIBA
01/2015
1Liposomes (Liposome)IBA
06/2014
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
06/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1Neutralizing AntibodiesIBA
11/2013
1AntibodiesIBA
03/2013
1Immunoglobulin M (IgM)IBA
03/2013
1Melitten (Melittin)IBA
02/2013
1Monoclonal AntibodiesIBA
02/2013
1Viral RNAIBA
01/2013
1Pharmaceutical PreparationsIBA
01/2013
1Conditioned Culture MediaIBA
04/2011
1Differentiation AntigensIBA
09/2010
1Histocompatibility Antigens Class IIBA
09/2010
1Complement System Proteins (Complement)IBA
09/2010
1Recombinant ProteinsIBA
11/2009
1Galectin 1 (LGALS1)IBA
11/2009
1Ribavirin (Virazole)FDA LinkGeneric
05/2007
1oleuropeinIBA
06/2005
1Plant ExtractsIBA
06/2005
1olive leaf extractIBA
06/2005
1Viral ProteinsIBA
06/2005
1Biological ProductsIBA
08/2004

Therapy/Procedure

1Therapeutics
01/2016